November 15, 2018
Patients with prior MI and elevated high-sensitivity C-reactive protein (hsCRP) see a dose-dependent reduction in heart-failure hospitalization while taking the anti-inflammatory drug canakinumab (Novartis), researchers reported Sunday at the American Heart Association (AHA) 2018 Scientific Sessions in Chicago, IL. The difference between canakinumab and placebo was only significant, however, among patients who achieved on-treatment hsCRP concentrations < 2 mg/L.
November 14, 2018
Mortality outcomes for patients undergoing TAVR in France are similar up to 3 years regardless of whether they underwent their procedure in a cath lab or a hybrid operating room (OR), according to new results from the FRANCE TAVI registry.
November 13, 2018
Ticagrelor monotherapy is no better than aspirin when it comes to reducing graft failure due to ischemic events occurring in the first year following CABG surgery, the TiCAB study showed.
November 09, 2018
VentureMed Group Inc. announced the initiation of a new study to determine if the Flex Dynamic Scoring Catheter reduces dissections and the need for bailout stents in peripheral arteries. The study, entitled “Arterial Dissections Following FLEX Scoring and Adjunctive Balloon Angioplasty: Intravascular Ultrasound Assessment and Correlation with Angiographic Findings,” will utilize intravascular ultrasound (IVUS) to identify the health of the vessel after treatment.
October 24, 2018
Ensuring use of proven medications for secondary prevention after MI may help mitigate the excess mortality risk seen in patients with schizophrenia, a Danish cohort study suggests.
October 23, 2018
Optical coherence tomography (OCT) can be a tool for better understanding the origins of MI with non-obstructive coronary arteries (MINOCA), a new single-center study suggests. Both plaque disruption and thrombus appear to be linked with myocardial injury, as assessed by cardiac magnetic resonance (CMR).
October 22, 2018
Full results of the secondary analysis looking at neurological events in the SURTAVI trial affirm that intermediate-risk patients who underwent TAVR with the self-expanding CoreValve (Medtronic) versus surgical aortic valve replacement (SAVR) fared better in the first 30 days of follow-up.
October 19, 2018
As TAVR volumes in the United States have grown, those of isolated surgical aortic valve replacement (SAVR) have dropped, as have the comorbidities of the patients treated surgically, according to observational data through 2014. Moreover, patient mortality following SAVR has decreased among the highest-volume TAVR centers.
October 18, 2018
Interventional cardiologists still have mixed perspectives on appropriate use criteria (AUC) for diagnostic catherization and percutaneous coronary interventions nearly a decade after the metrics debuted, according to results of a recent survey.
October 12, 2018
The US Food and Drug Administration (FDA) has added new indications for rivaroxaban (Xarelto; Bayer/Janssen) to include the treatment of patients with stable atherosclerotic vascular disease, both CAD and PAD, making the factor Xa inhibitor the first direct oral anticoagulant cleared for this use.